CIK 0001464521 · <br>Emerging growth company
Heartflow, Inc.
Sign in to watch- Ticker
- HTFL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260506743
- Phone
- 650-241-1221
- Business address
- 135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
- Former names
- Cardiovascular Simulation, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,602,722
- in 13 filings, $16.6M under 10b5-1 plans
Net −$16,602,722. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Farquhar John C.M. Chief Executive Officer | Option exercise 10b5-1 | +15,620 | $2.22 | $35K | 290,883 |
| 2026-11-10 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −38,900 | $55.74 | $2.2M | 251,983 |
| 2026-11-10 | Farquhar John C.M. Chief Executive Officer | Option exercise · Stock Option 10b5-1 | −15,620 | 1,969,017 | ||
| 2026-11-09 | Verghese Vikram Chief Financial Officer | Sale 10b5-1 | −3,587 | $53.15 | $191K | 149,587 |
| 2026-11-06 | Farquhar John C.M. Chief Executive Officer | Shares withheld for taxes 10b5-1 | −7,751 | $52.40 | $406K | 275,263 |
| 2026-11-06 | Verghese Vikram Chief Financial Officer | Shares withheld for taxes 10b5-1 | −2,009 | $52.40 | $105K | 153,174 |
| 2026-11-06 | Rogers Campbell Chief Medical Officer | Shares withheld for taxes | −2,270 | $52.40 | $119K | 71,183 |
| 2026-11-06 | Jones Marie L. Chief Accounting Officer | Shares withheld for taxes | −568 | $52.40 | $30K | 32,403 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +12,329 | $8.33 | $103K | 92,285 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +5,101 | $2.22 | $11K | 97,386 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −23,933 | $55.01 | $1.3M | 73,453 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −12,329 | 19,127 | ||
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −5,101 | 65,682 | ||
| 2026-10-12 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −38,900 | $49.57 | $1.9M | 283,014 |
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +12,329 | $8.33 | $103K | 98,788 |
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +850 | $2.22 | $2K | 99,638 |
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −19,682 | $50.15 | $987K | 79,956 |
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −12,329 | 31,456 | ||
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −850 | 70,783 | ||
| 2026-09-18 | Verghese Vikram Chief Financial Officer | Sale 10b5-1 | −16,766 | $50.75 | $851K | 155,183 |
Page 1 of 12 · 224 trades